Skip to content
DataLookout
Menu

HED-2TNCT07821294

Feasibility and Performance of FFPE qPCR for Detection of Clarithromycin Resistance in Helicobacter Pylori

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Start date changed from estimate of Sep 1, 2026 to Sep 10, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Diagnostic performance of q-PCR on FFPE gastric biopsies for detection of Helicobacter pylori clarithromycin resistance
Timeframe: Within 10 days after gastric biopsy collection

Secondary (5)

Prevalence of clarithromycin resistance in Helicobacter pylori infection
Concordance between q-PCR FFPE and immunohistochemistry results
Concordance between q-PCR FFPE and bacteriological PCR results
Impact of q-PCR results on therapeutic management
Medical-economic impact of q-PCR FFPE strategy

Arms and interventions

Diagnostic tests: q-PCR on FFPE gastric biopsies

Sites

1 site in 1 country

  • BenkessouParis, France